Literature DB >> 35004960

Adjuvant therapy for intrahepatic carcinoma after surgical resection: chemotherapy and future perspectives.

Wei Zhang1, Tianqiang Song1.   

Abstract

Entities:  

Year:  2021        PMID： 35004960      PMCID： PMC8683914          DOI： 10.21037/hbsn-21-368

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Authors:  John N Primrose; Richard P Fox; Daniel H Palmer; Hassan Z Malik; Raj Prasad; Darius Mirza; Alan Anthony; Pippa Corrie; Stephen Falk; Meg Finch-Jones; Harpreet Wasan; Paul Ross; Lucy Wall; Jonathan Wadsley; Jeff T R Evans; Deborah Stocken; Raaj Praseedom; Yuk Ting Ma; Brian Davidson; John P Neoptolemos; Tim Iveson; James Raftery; Shihua Zhu; David Cunningham; O James Garden; Clive Stubbs; Juan W Valle; John Bridgewater
Journal:  Lancet Oncol       Date:  2019-03-25       Impact factor: 41.316

2.  A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).

Authors:  Kohei Nakachi; Masaru Konishi; Masafumi Ikeda; Junki Mizusawa; Junko Eba; Takuji Okusaka; Hiroshi Ishii; Haruhiko Fukuda; Junji Furuse
Journal:  Jpn J Clin Oncol       Date:  2018-04-01       Impact factor: 3.019

3.  Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?

Authors:  Ariella M Altman; Scott Kizy; Schelomo Marmor; Jane Y C Hui; Todd M Tuttle; Eric H Jensen; Jason W Denbo
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 7.293

4.  Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.

Authors:  Guofang Liu; Wei Guo; Hao Wang; Wendi Liu; Liping Lei; Qiaohua Xie; Xiaoyan Li; Shanshan Zou; Peng Wang; Huabang Zhou; Heping Hu
Journal:  Ann Palliat Med       Date:  2021-02-23

Review 5.  Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Simona Tavolari; Giovanni Brandi
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 6.  Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.

Authors:  Angela Lamarca; Jorge Barriuso; Mairéad G McNamara; Juan W Valle
Journal:  J Hepatol       Date:  2020-03-12       Impact factor: 25.083

7.  Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation.

Authors:  Wei Zhang; Junping Shi; Rentao Li; Zhiqiang Han; Ling Li; Guanghao Li; Bo Yang; Qiang Yin; Yingying Wang; Yan Ke; Qiang Li
Journal:  Oncologist       Date:  2020-02-11

8.  Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.

Authors:  Alexander Stein; Dirk Arnold; John Bridgewater; David Goldstein; Lars Henrik Jensen; Heinz-Josef Klümpen; Ansgar W Lohse; Björn Nashan; John Primrose; Silke Schrum; Jenny Shannon; Eik Vettorazzi; Henning Wege
Journal:  BMC Cancer       Date:  2015-07-31       Impact factor: 4.430

9.  Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Ka Wing Ma; Tan To Cheung; Brian Leung; Brian Wong Hoi She; Kenneth Siu Ho Chok; Albert Chi Yan Chan; Wing Chiu Dai; Chung Mau Lo
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.

Authors:  Bingqi Ma; Huijuan Meng; Ye Tian; Yingying Wang; Tianqiang Song; Ti Zhang; Qiang Wu; Yunlong Cui; Huikai Li; Wei Zhang; Qiang Li
Journal:  BMC Cancer       Date:  2020-04-15       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.